THE DUAL DIAGNOSIS: SCHIZOPHRENIA AND SUBSTANCE ABUSE


Cite item

Full Text

Abstract

The concept of dual diagnosis means the comorbidity of mental disorders and substance abuse. The prevalence of substance use disorders in the mentally ill and, conversely, the prevalence of mental disorders in the substance users significantly exceed population values, indicating a certain mutual conditioning of both types of disorders. An example of a dual diagnosis is the combination of schizophrenia and addictive disorders. Substance abuse in patients with schizophrenia is associated with worsening of its course, which is manifested by more frequent relapses, increased severity of psychosis, more frequent hospitalizations, lower adherence to therapy, the need for higher doses of antipsychotics, increased incidence of extrapyramidal disorders, a tendency to aggression and violence, and exacerbation of suicidal tendencies. Treatment of patients with a dual diagnosis requires special approaches, and the therapy success depends on a number of conditions including inclusiveness, low thresholds of treatment programs, confidentiality, and transparency of the treatment methods used for patients and their relatives.

About the authors

Yury P Sivolap

I.M. Sechenov First Moscow State Medical University

Email: yura-sivolap@yandex.ru
Department of Psychiatry and Addiction 119991,Trubetskaya Str., 8 (2), Moscow

Maxim V Yanushkevich

I.M. Sechenov First Moscow State Medical University

Department of Psychiatry and Addiction 119991,Trubetskaya Str., 8 (2), Moscow

Vladimir A Savchenkov

I.M. Sechenov First Moscow State Medical University

Department of Psychiatry and Addiction 119991,Trubetskaya Str., 8 (2), Moscow

References

  1. Менделевич В.Д. Психотические расстройства в результате употребления наркотиков: современное состояние проблемы // Наркология. 2014. №7. С. 93-100.
  2. Alderson H.L., Semple D.M., Blayney C. et al. Risk of transition to schizophrenia following first admission with substance-induced psychotic disorder: a population-based longitudinal cohort study // Psychol-Med 2017. Vol. 3. P. 1-8.
  3. Balhara Y.P., Kuppili P.P., Gupta R. Neurobiology of comorbid substance use disorders and psychiatric disorders: current state of evidence // J-Addict-Nurs 2017. Vol. 28 (1). P. 11-26.
  4. Belli H., Ural C. The association between schizophrenia and violent or homicidal behaviour: the prevention and treatment of violent behaviour in these patients // West-Indian-Med-J. 2012. Vol. 61 (5). P. 538-543.
  5. Castle D.J., Buckley P.F. Schizophrenia. Second Revised Edition. Oxford: Oxford University Press, 2012. 132 p.
  6. Coentre R., Talina M.C., Góis C., Figueira M.L. Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review // Psychiatry-Res. 2017. Vol. 253. P. 240-248.
  7. Dervaux A., Laqueille X., Bourdel M.C. et al. Cannabis and schizophrenia: demographic and clinical correlates // Encephale. 2003. Vol. 29 (1). P. 11-17.
  8. Gouzoulis-Mayfrank E. Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment // Z-Kinder-Jugendpsychiatr-Psychother 2008. Vol. 36 (4). P. 245-253.
  9. Gouzoulis-Mayfrank E., Walter M. Schizophrenia and Addiction. In: Geert Dom Franz Moggi (Editors). Co-occurring Addictive and Psychiatric Disorders. A Practice-Based Handbook from a European Perspective. Berlin: Springer, 2015. P. 75-86.
  10. Kudumija Slijepcevic M., Jukic V., Novalic D. et al. Alcohol abuse as the strongest risk factor for violent offending in patients with paranoid schizophrenia // Croat-Med-J 2014. Vol. 55 (2). P. 156-162.
  11. Mueser K.T., Gingerich S. Treatment of co-occurring psychotic and substance use disorders // Soc-Work-Public-Health 2013. Vol. 28 (3-4). P. 424-439.
  12. Niemi-Pynttäri J.A., Sund R., Putkonen H. et al. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases // J-Clin-Psychiatry. 2013. Vol. 74 (1). e94-99.
  13. Velligan D.I., Sajatovic M., Hatch A. et al. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness // Patient-Prefer-Adherence, 2017. Vol. 11. P. 449-468.

Copyright (c) 2017 Sivolap Y.P., Yanushkevich M.V., Savchenkov V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies